Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management

Pediatric Transplantation - Tập 20 Số 6 - Trang 756-769 - 2016
Kimihiko Oishi1, Ronen Arnon2,3, Melissa P. Wasserstein1, George A. Díaz1
1Departments of Pediatrics Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai New York NY USA
2Departments of Pediatrics Pediatric Gastroenterology and Hepatology Icahn School of Medicine at Mount Sinai New York NY USA
3The Recanati/Miller Transplantation Institute Mount Sinai Medical Center New York NY USA

Tóm tắt

AbstractLT is an effective therapeutic option for a variety of IEM. This approach can significantly improve the quality of life of patients who suffer from severe disease manifestations and/or life‐threatening metabolic decompensations despite medical/dietary management. Due to the significant risks for systemic complications from surgical stressors, careful perioperative management is vital. Even after LT, some disorders require long‐term dietary restriction, medical management, and monitoring of metabolites. Successful liver transplant for these complex disorders can be achieved with disease‐ and patient‐specific strategies using a multidisciplinary approach. In this article, we review indications, complications, perioperative management, and long‐term follow‐up recommendations for IEM that are treatable with LT.

Từ khóa


Tài liệu tham khảo

10.1016/S0022-3476(89)80843-1

Mowat AP, 1987, Liver disorders in children: The indications for liver replacement in parenchymal and metabolic diseases, Transplant Proc, 19, 3236

10.1016/j.ymgme.2014.02.013

10.1111/j.1399-3046.2010.01339.x

10.1002/lt.22293

10.1097/MOT.0000000000000121

10.1097/MOG.0000000000000173

10.1093/ajcn/68.1.72

10.1111/petr.12196

1997 Seattle Copyright University of Washington L Sniderman King C Trahms CR Scott [Updated 2014 Jul 17]. Tyrosinemia type I. In: GeneReviews at GeneTests Medical Genetics Information Resource (database online)

10.1007/PL00014321

10.1016/0140-6736(92)92685-9

10.2165/00003495-200666060-00002

10.1517/14656566.9.7.1229

10.1007/s10545-008-0817-x

10.1007/s10545-012-9482-1

10.1007/s10545-005-0059-0

10.1038/ng1293-327

10.1038/ng1293-344

10.1039/C2MT20151H

10.1016/B978-0-12-410502-7.00014-4

10.1111/nyas.12454

10.4254/wjh.v4.i1.5

10.1001/archneur.57.3.384

10.1016/j.jhep.2013.10.025

10.1002/lt.20486

10.1007/s11894-013-0367-8

10.1002/lt.23744

10.1002/hep.27086

10.1182/blood-2012-05-423186

10.1016/S0140-6736(04)15646-8

10.1016/j.bpg.2004.10.006

10.7326/0003-4819-142-6-200503150-00010

10.1002/lt.22345

10.1136/jclinpath-2012-200791

10.1159/000338354

10.1111/j.1432-2277.2009.01035.x

10.1046/j.1365-2796.2000.00743.x

10.1001/archderm.1980.01640280065021

10.1002/lt.20620

10.1002/lt.22341

10.1016/0016-5085(91)90680-J

10.1002/hep.1840180619

1997 Seattle Copyright University of Washington KA Strauss EG Puffenberger DH Morton Maple syrup urine disease. In: GeneReviews at GeneTests Medical Genetics Information Resource (database online)

10.1016/j.jpeds.2011.06.033

10.1111/j.1600-6143.2005.01209.x

10.1097/00000542-197601000-00023

10.1111/j.1365-2044.1996.tb12568.x

10.1093/bja/aen341

1997 Seattle Copyright University of Washington N Ah Mew BC Lanpher A Gropman (Updated 2015 Apr 9). Urea cycle disorders overview. In: GeneReviews at GeneTests Medical Genetics Information Resource (database online)

10.1111/petr.12041

10.1016/j.ymgme.2003.08.027

10.1002/lt.20587

10.1111/j.1399-3046.2011.01494.x

10.1016/0022-3468(95)90766-1

10.1007/8904_2013_218

10.1111/j.1399-3046.2012.01716.x

10.1067/mpd.2001.111834

10.1002/lt.500040504

10.1111/j.1399-3046.2010.01402.x

10.1038/nrendo.2010.189

10.1007/PL00014320

10.1111/j.1399-3046.2007.00803.x

10.1007/BF02072093

10.1007/BF01954384

10.1007/BF02072092

10.1097/00005176-199703000-00008

10.1186/1750-1172-9-47

10.1111/j.1399-3046.2012.01705.x

10.1002/lt.21929

10.1002/pbc.22706

10.1016/0016-5085(91)90229-E

10.1097/00054725-200105000-00008

10.1007/s00467-006-0077-7

10.1016/j.jhep.2007.05.012

10.1007/BF02680007

10.1172/JCI118799

Shimizu J, 1982, A report on an adult case of type III glycogenosis with primary liver cancer and liver cirrhosis, Nihon Shokakibyo Gakkai Zasshi, 79, 2328

10.1056/NEJM199303183281101

Choleva AJ, 2011, Anesthesia considerations in a patient with McArdle disease: A case report, AANA J, 79, 243

10.1111/j.1460-9592.2010.03292.x

10.1046/j.1460-9592.2002.00942.x

10.1007/BF02679990

10.1056/NEJMoa021744

10.1172/JCI115829

10.1007/s00431-005-0055-2

10.1016/S0022-3468(03)00273-2

10.1016/S0973-6883(11)60132-1

10.1213/00000539-199201000-00031

10.1213/01.ane.0000252462.70451.0e

10.1056/NEJMra1301564

10.1159/000184364

10.7196/SAMJ.7304

10.1007/PL00014327

Jamieson NV, 1998, The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984‐1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group, J Nephrol, 11, 36

10.1007/BF00864408

10.1111/petr.12376

10.1002/lt.24009

10.1055/s-0031-1272831

10.1111/j.1440-1746.2005.03743.x

10.1034/j.1399-3046.1999.00046.x

10.1016/j.jpedsurg.2011.08.010

10.1111/j.1399-3046.2007.00722.x

10.1097/01.tp.0000282869.94152.4f

10.1016/j.jhep.2010.05.025

10.1056/NEJMoa0901075

10.1007/s12016-014-8457-4

10.1002/hep.28311

10.1002/lt.23754

10.4103/0974-2069.132478

1997 Seattle Copyright University of Washington E Youngblom JW Knowles (2014 Jan 2). Familial hypercholesterolemia. In: GeneReviews at GeneTests Medical Genetics Information Resource (database online)

10.1111/imj.12444

10.1097/MOL.0b013e32836308bc

10.5551/jat.14.94

10.1007/s12265-011-9311-1

10.1016/j.transproceed.2005.03.037

10.1016/j.ymgme.2014.01.006

1997 Seattle Copyright University of Washington N Carrillo‐Carrasco C Venditti Propionic acidemia. In: GeneReviews at GeneTests Medical Genetics Information Resource (database online)

1997 Seattle Copyright University of Washington I Manoli JL Sloan CP Venditti (Updated 2016 Jan 7). Methylmalonic acidemia. In: GeneReviews at GeneTests Medical Genetics Information Resource (database online)

10.1016/j.ymgme.2007.08.119

10.1016/j.jpeds.2009.07.002

10.1111/j.1399-3046.2006.00569.x

10.1016/j.jcma.2012.03.004

10.1007/s10545-005-0517-8

10.1111/j.1744-9987.2011.00974.x

10.1007/PL00014325

10.1111/j.1399-3046.2009.01227.x

10.1111/j.1399-3046.2006.00585.x

10.1056/NEJMra1012478

Pfeffer G, 2012, Treatment for mitochondrial disorders, Cochrane Database Syst Rev, 4, CD004426

10.1007/s11940-014-0292-7

10.1016/j.jpeds.2013.05.036

10.1016/S0022-3476(97)80027-3

10.1002/lt.21556

10.1007/PL00014328

10.1111/pan.12158

10.1007/s11940-009-0046-0

10.1111/petr.12439

10.1590/1414-431X20143830

10.1111/petr.12447

10.1111/j.1460-9592.2010.03322.x

Iida R, 1996, Anesthetic management of a patient with ornithine transcarbamylase deficiency, Masui, 45, 642

10.1111/j.1460-9592.2005.01695.x

Arcas‐Bellas JJ, 2013, General anesthesia in an adult female with propionic acidemia: Anesthetic considerations, Minerva Anestesiol, 79, 313

10.1097/00000539-200008000-00014

10.1111/j.1460-9592.2006.01992.x

10.1097/EJA.0b013e3283405119

Sanchez‐Rodenas L, 2005, Infant boy with propionic acidemia: Anesthetic implications, Rev Esp Anestesiol Reanim, 52, 429

10.3109/09637489809089409

10.1111/j.1399-0012.2009.01203.x

Thông tin
Thông tin xuất bản

Pediatric Transplantation

Tập 20 Số 6

756-769

Thông tin tác giả